Cross‐sectional and Mendelian randomization study of fibroblast growth factor 19 reveals causal associations with metabolic diseases

Background and Aim Fibroblast growth factor 19 (FGF19) is an intestinal‐derived factor that plays a role in metabolic diseases. We performed a differential study of circulating FGF19 levels and investigated the causal effects of FGF19 on metabolic diseases using Mendelian randomization (MR). Methods...

Full description

Saved in:
Bibliographic Details
Published in:Journal of gastroenterology and hepatology Vol. 39; no. 12; pp. 2872 - 2879
Main Authors: Li, Yan, Dai, Changyong, Yang, Haiqing, Zeng, Huang, Ruan, Yuhua, Dai, Mingjia, Hao, Jungui, Wang, Liping, Yan, Xuebing, Ji, Fang
Format: Journal Article
Language:English
Published: Australia Wiley Subscription Services, Inc 01.12.2024
Subjects:
ISSN:0815-9319, 1440-1746, 1440-1746
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first